MIRABILE, AURORA
MIRABILE, AURORA
Universita' degli Studi di MILANO
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab : An exploratory study
2021 V.D.A. Corino, M. Bologna, G. Calareso, L. Licitra, M. Ghi, G. Rinaldi, F. Caponigro, F. Morelli, M. Airoldi, G. Allegrini, A. Cassano, D. Ferrari, A. Mirabile, A. Tosoni, D. Galizia, M. Merlano, A. Sponghini, G. Moretti, L. Mainardi, P. Bossi
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas : Translational analyses and clinical impact
2016 L.D. Locati, F. Perrone, B. Cortelazzi, C. Bergamini, P. Bossi, E. Civelli, C. Morosi, S. Lo Vullo, M. Imbimbo, P. Quattrone, G.P. Dagrada, R. Granata, C. Resteghini, A. Mirabile, S. Alfieri, E. Orlandi, L. Mariani, G. Saibene, S. Pilotti, L. Licitra
A single-arm, open-label, multicenter, phase IIIb clinical trial with nivolumab in subjects with recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck
2019 P. Bossi, M.C. Merlano, M.G. Ghi, G. Rinaldi, F. Caponigro, F. Morelli, M. Airoldi, A. Farnesi, A. Cassano, D. Ferrari, A. Mirabile, A. Tosoni, D. Galizia, G. Moretti, A.P. Sponghini, G. Calareso, A. Vingiani, F. Perrone, A. Falletta, L.F. Licitra
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis : a randomized, double-blind study
2015 F. Roila, B. Ruggeri, E. Ballatori, S. Fatigoni, C. Caserta, L. Licitra, A. Mirabile, M.T. Ionta, B. Massidda, L. Cavanna, M.A. Palladino, A. Tocci, S. Fava, I. Colantonio, L. Angelelli, A.L. Ciuffreda, G. Fasola, F. Zerilli
Comment on "acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN) : A matched pair analysis", by Rades et coll
2010 P. Bossi, R. Granata, C. Bergamini, A. Mirabile, L. Locati, L. Licitra
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer
2011 P. Bossi, E. Orlandi, C. Bergamini, L.D. Locati, R. Granata, A. Mirabile, D.P. Franceschini, C. Fallai, P. Olmi, P. Quattrone, P. Potepan, A. Gloghini, R. Miceli, F. Mattana, G. Scaramellini, L. Licitra
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer
2014 P. Bossi, L. Locati, C. Bergamini, A. Mirabile, R. Granata, M. Imbimbo, C. Resteghini, L. Licitra
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy
2016 A. Mirabile, C. Vismara, F. Crippa, P. Bossi, L. Locati, C. Bergamini, R. Granata, C. Resteghini, E. Conte, D. Morelli, P. Scarpellini, L. Licitra
Italian version of the M.D. Anderson Symptom Inventory - Head and Neck Module : linguistic validation
2015 A. Greco, E. Orlandi, A. Mirabile, S. Takanen, C. Fallai, N.A. Iacovelli, A. Rimedio, E. Russi, M. Sala, D. Monzani, D.I. Rosenthal, G.B. Gunn, P. Steca, L. Licitra, P. Bossi
MALT lymphoma and Kaposi Sarcoma in an HIV-negative patient
2010 A. Mirabile, L. Devizzi, A. Gianni, A. Cabras, A. Carbone
Pain management in head and neck cancer patients undergoing chemo-radiotherapy : Clinical practical recommendations
2016 A. Mirabile, M. Airoldi, C. Ripamonti, A. Bolner, B. Murphy, E. Russi, G. Numico, L. Licitra, P. Bossi
Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer
2019 E. Orlandi, R. Miceli, G. Infante, A. Mirabile, D. Alterio, M. Cossu Rocca, N. Denaro, R. Vigna-Taglianti, A. Merlotti, A. Schindler, N. Pizzorni, C. Fallai, L. Licitra, P. Bossi
Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck
2019 A. Mirabile, R. Miceli, R.G. Calderone, L. Locati, P. Bossi, C. Bergamini, R. Granata, F. Perrone, L. Mariani, L. Licitra
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients
2021 S. Alfieri, R. Romano, M. Bologna, G. Calareso, V. Corino, A. Mirabile, A. Ferri, L. Bellanti, T. Poli, A. Marcantoni, E. Grosso, A. Tarsitano, S. Battaglia, F. Blengio, I. De Martino, S. Valerini, S. Vecchio, A. Richetti, L. Deantonio, F. Martucci, A. Grammatica, M. Ravanelli, T. Ibrahim, D. Caruso, L.D. Locati, E. Orlandi, P. Bossi, L. Mainardi, L.F. Licitra
Sepsis in head and neck cancer patients treated with chemotherapy and radiation : literature review and consensus
2015 A. Mirabile, G. Numico, E.G. Russi, P. Bossi, F. Crippa, A. Bacigalupo, V. De Sanctis, S. Musso, A. Merlotti, M.G. Ghi, M.C. Merlano, L. Licitra, F. Moretto, N. Denaro, O. Caspiani, M. Buglione, S. Pergolizzi, A. Cascio, J. Bernier, J. Raber Durlacher, J.B. Vermorken, B. Murphy, M.V. Ranieri, R.P. Dellinger
Targeted therapy in head and neck cancer
2011 L. Licitra, C. Bergamini, A. Mirabile, R. Granata
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers
2023 A. Trama, L. Licitra, S. Cavalieri, S. Bonfarnuzzo, P. Baili, A. Ciarfella, P. Parente, G. Almadori, M. Ansarin, A. Bacigalupo, P. Baumeister, B. Baujat, P. Bossi, E. Cavalera, M.C. Cercato, F. Dieleman, N. Fakhry, V. Ferraresi, F. Gaino, D. Galizia, J. Halamkova, E. Halme, J. Hardillo, B. Hofauer, E. Kinloch, L. Livi, L.D. Locati, S. Mattheis, G. Mercante, A. Mirabile, G. Molteni, E. Orlandi, R. Persio, S. Sciallero, L. Smeele, M. Tagliabue, V. Valentini, C. Van Harpen, C.B. Westphalen, L. Botta
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer : An Italian validation study
2012 R. Granata, R. Miceli, E. Orlandi, F. Perrone, B. Cortelazzi, M. Franceschini, L.D. Locati, P. Bossi, C. Bergamini, A. Mirabile, L. Mariani, P. Olmi, G. Scaramellini, P. Potepan, P. Quattrone, K.K. Ang, L. Licitra